Global Glucagon Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Summary
Market Overview
The global Glucagon market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.8% in the forecast period of 2020 to 2025 and will expected to reach USD 634.7 million by 2025, from USD 505.9 million in 2019.
The Glucagon market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Glucagon market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Glucagon market has been segmented into Inject Glucagon, Nasal Glucagon, etc.
By Application, Glucagon has been segmented into Emergency Kits, General Use, Diagnostic & Motility, Cardiogenic Shock, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Glucagon market presented in the report. This section sheds light on the sales growth of different regional and country-level Glucagon markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Glucagon market.
The report offers in-depth assessment of the growth and other aspects of the Glucagon market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Glucagon markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Glucagon Market Share Analysis
Glucagon competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Glucagon sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Glucagon sales, revenue and market share for each player covered in this report.
The major players covered in Glucagon are: Novo Nordisk, Torrent Labs, Eli Lilly, Fresenius Kabi, Xeris Pharmaceuticals, Taj Pharmaceuticals, etc. Among other players domestic and global, Glucagon market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glucagon, with price, sales, revenue and global market share of Glucagon in 2018 and 2019.
Chapter 3, the Glucagon competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Glucagon market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Glucagon sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Glucagon Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glucagon Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Market Analysis by Application
1.3.1 Overview: Global Glucagon Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Overview of Global Glucagon Market
1.4.1 Global Glucagon Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novo Nordisk SWOT Analysis
2.1.4 Novo Nordisk Product and Services
2.1.5 Novo Nordisk Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Torrent Labs
2.2.1 Torrent Labs Details
2.2.2 Torrent Labs Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Torrent Labs SWOT Analysis
2.2.4 Torrent Labs Product and Services
2.2.5 Torrent Labs Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli Lilly SWOT Analysis
2.3.4 Eli Lilly Product and Services
2.3.5 Eli Lilly Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Fresenius Kabi
2.4.1 Fresenius Kabi Details
2.4.2 Fresenius Kabi Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Fresenius Kabi SWOT Analysis
2.4.4 Fresenius Kabi Product and Services
2.4.5 Fresenius Kabi Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Xeris Pharmaceuticals
2.5.1 Xeris Pharmaceuticals Details
2.5.2 Xeris Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Xeris Pharmaceuticals SWOT Analysis
2.5.4 Xeris Pharmaceuticals Product and Services
2.5.5 Xeris Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Taj Pharmaceuticals
2.6.1 Taj Pharmaceuticals Details
2.6.2 Taj Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Taj Pharmaceuticals SWOT Analysis
2.6.4 Taj Pharmaceuticals Product and Services
2.6.5 Taj Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Glucagon Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Glucagon Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Glucagon Manufacturer Market Share in 2019
3.3.2 Top 6 Glucagon Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Glucagon Sales, Revenue and Market Share by Regions
4.1.1 Global Glucagon Sales and Market Share by Regions (2015-2020)
4.1.2 Global Glucagon Revenue and Market Share by Regions (2015-2020)
4.2 North America Glucagon Sales and Growth Rate (2015-2020)
4.3 Europe Glucagon Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Glucagon Sales and Growth Rate (2015-2020)
4.5 South America Glucagon Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Glucagon Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Glucagon Sales, Revenue and Market Share by Country
5.1.1 North America Glucagon Sales and Market Share by Country (2015-2020)
5.1.2 North America Glucagon Revenue and Market Share by Country (2015-2020)
5.2 United States Glucagon Sales and Growth Rate (2015-2020)
5.3 Canada Glucagon Sales and Growth Rate (2015-2020)
5.4 Mexico Glucagon Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Glucagon Sales, Revenue and Market Share by Country
6.1.1 Europe Glucagon Sales and Market Share by Country (2015-2020)
6.1.2 Europe Glucagon Revenue and Market Share by Country (2015-2020)
6.2 Germany Glucagon Sales and Growth Rate (2015-2020)
6.3 UK Glucagon Sales and Growth Rate (2015-2020)
6.4 France Glucagon Sales and Growth Rate (2015-2020)
6.5 Russia Glucagon Sales and Growth Rate (2015-2020)
6.6 Italy Glucagon Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Glucagon Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Glucagon Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Glucagon Revenue and Market Share by Regions (2015-2020)
7.2 China Glucagon Sales and Growth Rate (2015-2020)
7.3 Japan Glucagon Sales and Growth Rate (2015-2020)
7.4 Korea Glucagon Sales and Growth Rate (2015-2020)
7.5 India Glucagon Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Glucagon Sales and Growth Rate (2015-2020)
7.7 Australia Glucagon Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Glucagon Sales, Revenue and Market Share by Country
8.1.1 South America Glucagon Sales and Market Share by Country (2015-2020)
8.1.2 South America Glucagon Revenue and Market Share by Country (2015-2020)
8.2 Brazil Glucagon Sales and Growth Rate (2015-2020)
8.3 Argentina Glucagon Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Glucagon Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Glucagon Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Glucagon Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Glucagon Sales and Growth Rate (2015-2020)
9.3 Turkey Glucagon Sales and Growth Rate (2015-2020)
9.4 Egypt Glucagon Sales and Growth Rate (2015-2020)
9.5 South Africa Glucagon Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Glucagon Sales and Market Share by Type (2015-2020)
10.2 Global Glucagon Revenue and Market Share by Type (2015-2020)
10.3 Global Glucagon Price by Type (2015-2020)
11 Global Glucagon Market Segment by Application
11.1 Global Glucagon Sales Market Share by Application (2015-2020)
11.2 Global Glucagon Revenue Market Share by Application (2015-2020)
11.3 Global Glucagon Price by Application (2015-2020)
12 Market Forecast
12.1 Global Glucagon Sales, Revenue and Growth Rate (2021-2025)
12.2 Glucagon Market Forecast by Regions (2021-2025)
12.2.1 North America Glucagon Market Forecast (2021-2025)
12.2.2 Europe Glucagon Market Forecast (2021-2025)
12.2.3 Asia-Pacific Glucagon Market Forecast (2021-2025)
12.2.4 South America Glucagon Market Forecast (2021-2025)
12.2.5 Middle East & Africa Glucagon Market Forecast (2021-2025)
12.3 Glucagon Market Forecast by Type (2021-2025)
12.3.1 Global Glucagon Sales Forecast by Type (2021-2025)
12.3.2 Global Glucagon Market Share Forecast by Type (2021-2025)
12.4 Glucagon Market Forecast by Application (2021-2025)
12.4.1 Global Glucagon Sales Forecast by Application (2021-2025)
12.4.2 Global Glucagon Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Tables and Figures
List of Tables
Table 1. Global Glucagon Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Glucagon by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Glucagon Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 8. Novo Nordisk Glucagon Major Business
Table 9. Novo Nordisk Glucagon Total Revenue (USD Million) (2017-2018)
Table 10. Novo Nordisk SWOT Analysis
Table 11. Novo Nordisk Glucagon Product and Services
Table 12. Novo Nordisk Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Torrent Labs Basic Information, Manufacturing Base and Competitors
Table 14. Torrent Labs Glucagon Major Business
Table 15. Torrent Labs Glucagon Total Revenue (USD Million) (2017-2018)
Table 16. Torrent Labs SWOT Analysis
Table 17. Torrent Labs Glucagon Product and Services
Table 18. Torrent Labs Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly Glucagon Major Business
Table 21. Eli Lilly Glucagon Total Revenue (USD Million) (2017-2018)
Table 22. Eli Lilly SWOT Analysis
Table 23. Eli Lilly Glucagon Product and Services
Table 24. Eli Lilly Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 26. Fresenius Kabi Glucagon Major Business
Table 27. Fresenius Kabi Glucagon Total Revenue (USD Million) (2017-2018)
Table 28. Fresenius Kabi SWOT Analysis
Table 29. Fresenius Kabi Glucagon Product and Services
Table 30. Fresenius Kabi Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Xeris Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Xeris Pharmaceuticals Glucagon Major Business
Table 33. Xeris Pharmaceuticals Glucagon Total Revenue (USD Million) (2017-2018)
Table 34. Xeris Pharmaceuticals SWOT Analysis
Table 35. Xeris Pharmaceuticals Glucagon Product and Services
Table 36. Xeris Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 38. Taj Pharmaceuticals Glucagon Major Business
Table 39. Taj Pharmaceuticals Glucagon Total Revenue (USD Million) (2017-2018)
Table 40. Taj Pharmaceuticals SWOT Analysis
Table 41. Taj Pharmaceuticals Glucagon Product and Services
Table 42. Taj Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global Glucagon Sales by Manufacturer (2018-2019) (K MT)
Table 44. Global Glucagon Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global Glucagon Sales by Regions (2015-2020) (K MT)
Table 46. Global Glucagon Sales Market Share by Regions (2015-2020)
Table 47. Global Glucagon Revenue by Regions (2015-2020) (USD Million)
Table 48. North America Glucagon Sales by Countries (2015-2020) (K MT)
Table 49. North America Glucagon Sales Market Share by Countries (2015-2020)
Table 50. North America Glucagon Revenue by Countries (2015-2020) (USD Million)
Table 51. North America Glucagon Revenue Market Share by Countries (2015-2020)
Table 52. Europe Glucagon Sales by Countries (2015-2020) (K MT)
Table 53. Europe Glucagon Sales Market Share by Countries (2015-2020)
Table 54. Europe Glucagon Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific Glucagon Sales by Regions (2015-2020) (K MT)
Table 56. Asia-Pacific Glucagon Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific Glucagon Revenue by Regions (2015-2020) (USD Million)
Table 58. South America Glucagon Sales by Countries (2015-2020) (K MT)
Table 59. South America Glucagon Sales Market Share by Countries (2015-2020)
Table 60. South America Glucagon Revenue by Countries (2015-2020) (USD Million)
Table 61. South America Glucagon Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Glucagon Sales by Countries (2015-2020) (K MT)
Table 63. Middle East & Africa Glucagon Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa Glucagon Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa Glucagon Revenue Market Share by Countries (2015-2020)
Table 66. Global Glucagon Sales by Type (2015-2020) (K MT)
Table 67. Global Glucagon Sales Share by Type (2015-2020)
Table 68. Global Glucagon Revenue by Type (2015-2020) (USD Million)
Table 69. Global Glucagon Revenue Share by Type (2015-2020)
Table 70. Global Glucagon Sales by Application (2015-2020) (K MT)
Table 71. Global Glucagon Sales Share by Application (2015-2020)
Table 72. Global Glucagon Sales Forecast by Regions (2021-2025) (K MT)
Table 73. Global Glucagon Market Share Forecast by Regions (2021-2025)
Table 74. Global Glucagon Sales Forecast by Type (2021-2025) (K MT)
Table 75. Global Glucagon Market Share Forecast by Type (2021-2025)
Table 76. Global Glucagon Sales Forecast by Application (2021-2025)
Table 77. Global Glucagon Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Glucagon Picture
Figure 2. Global Sales Market Share of Glucagon by Type in 2019
Figure 3. Inject Glucagon Picture
Figure 4. Nasal Glucagon Picture
Figure 5. Glucagon Sales Market Share by Application in 2018
Figure 6. Emergency Kits Picture
Figure 7. General Use Picture
Figure 8. Diagnostic & Motility Picture
Figure 9. Cardiogenic Shock Picture
Figure 10. Others Picture
Figure 11. Global Glucagon Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Glucagon Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Glucagon Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Glucagon Sales Market Share by Manufacturer in 2019
Figure 32. Global Glucagon Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Glucagon Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Glucagon Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 37. Global Glucagon Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Glucagon Revenue Market Share by Regions (2015-2020)
Figure 39. Global Glucagon Revenue Market Share by Regions in 2018
Figure 40. North America Glucagon Sales and Growth Rate (2015-2020)
Figure 41. Europe Glucagon Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Glucagon Sales and Growth Rate (2015-2020)
Figure 43. South America Glucagon Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Glucagon Sales and Growth Rate (2015-2020)
Figure 45. North America Glucagon Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Glucagon Sales Market Share by Countries (2015-2020)
Figure 47. North America Glucagon Sales Market Share by Countries in 2018
Figure 48. North America Glucagon Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Glucagon Revenue Market Share by Countries in 2018
Figure 50. United States Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Canada Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Mexico Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Europe Glucagon Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Glucagon Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Glucagon Revenue Market Share by Countries in 2019
Figure 56. Germany Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 57. UK Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 58. France Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Russia Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Italy Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Asia-Pacific Glucagon Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Glucagon Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Glucagon Revenue Market Share by Regions 2019
Figure 64. China Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Japan Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Korea Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 67. India Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Southeast Asia Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 69. South America Glucagon Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Glucagon Sales Market Share by Countries in 2019
Figure 71. South America Glucagon Revenue Market Share by Countries in 2019
Figure 72. Brazil Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Argentina Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Middle East and Africa Glucagon Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Glucagon Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Glucagon Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Glucagon Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Egypt Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Turkey Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 81. South Africa Glucagon Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Global Glucagon Sales and Growth Rate (2021-2025) (K MT)
Figure 83. Global Glucagon Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Glucagon Market Forecast (2021-2025) (K MT)
Figure 85. Europe Sales Glucagon Market Forecast (2021-2025) (K MT)
Figure 86. Asia-Pacific Sales Glucagon Market Forecast (2021-2025) (K MT)
Figure 87. South America Sales Glucagon Market Forecast (2021-2025) (K MT)
Figure 88. Middle East & Africa Sales Glucagon Market Forecast (2021-2025) (K MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets